BPC-157 — research catalogue reference

Aussie Peptides lists BPC-157 for in-vitro laboratory research only and does not offer, advertise or describe it as a treatment.

A research-use label does not by itself determine regulatory status; the compliance page links to the official TGA guidance. Buyers must be 18 or over and handle it in line with their institution's requirements.

BPC-157 is also prohibited at all times in sport. Sport Integrity Australia lists it under the WADA S0 (non-approved substances) category, so athletes subject to anti-doping rules should not handle it outside a research setting.

Rules can change. Check the TGA and Sport Integrity Australia sources linked at the bottom of this page for the current position.

It is listed here as a laboratory reference material for in-vitro research only and is not offered for human or veterinary use. Regulatory status is not determined by a research-use label; see the compliance page for official TGA guidance.

The BPC-157 literature is overwhelmingly preclinical: cell-culture and rodent models examining tissue-repair signalling, angiogenesis-related pathways, tendon and ligament fibroblast behaviour, and gastrointestinal mucosal models.

Human clinical evidence is limited and we make no claims about effects in humans. Read the primary sources linked at the bottom of this page and assess the methodology yourself.

TB-500 (a synthetic fragment of thymosin beta-4) appears alongside BPC-157 in the tissue-repair research literature, but the two are structurally unrelated and are studied through different mechanistic pathways — TB-500 work centres on actin binding and cell migration, BPC-157 work on angiogenesis-related and gastrointestinal signalling.

The catalogue lists BPC-157 as single vials (5mg and 10mg) and in blends (BPC-157 + TB-500 10mg, 5mg of each; Wolverine 20mg, 10mg of each). Not every format is in stock at once; each product page shows current availability and the price including GST.

Orders are sent by tracked Australia Post express. Rates and the free-shipping threshold are on the shipping policy page; delivery times are carrier estimates, not guarantees.

Aussie Peptides does not publish product- or lot-specific preparation, storage or stability data. Base preparation, storage and disposal on the supplier safety data sheet (SDS) and your institution's standard operating procedures.

Where a vial label shows a lot number and a batch report has been published for that lot, it can be looked up on the verify page and recorded alongside your experimental data.

Materials on this site are supplied strictly for in-vitro laboratory research. They are not offered for human or veterinary use. A research-use label does not by itself determine regulatory status; see the compliance page for official TGA guidance.

Purchasers must be 18 or over and are responsible for handling, storing and disposing of research materials in line with their institution's requirements and applicable Australian law.

Nothing on this page is medical advice, a dosing protocol, or a claim of therapeutic benefit. It summarises what the published research literature investigates.